Recruiting Solid Tumor Patients in a Complex ADME Trial
Recruiting Solid Tumor Patients in a Complex ADME Trial
3 PagesCASE STUDY Recruiting Solid Tumor Patients in a Complex ADME Trial Patient Pharmacology Services Completes Enrollment Ahead of ScheduleRecruiting Solid Tumor Patients in a Complex ADME Trial Patient Pharmacology Services Completes Enrollment Ahead of Schedule Regions Central Europe Eastern Europe STUDY DESCRIPTION An open-label, non-randomized, Phase I study to assess the absorption, distribution, metabolism, and excretion (ADME) following a single oral dose of the study drug in patients with advanced solid tumors Study Duration 11 months No. of Clinical Sites 1 Single Patient Pharmacology Service (PPS) Site in Budapest, Hungary Treatment Period 13 days maximum (part 1) 28 Days (part 2 - optional) After completing Part I, patients with deleterious BRCA1/2 mutations may
